"CaptHPV : Validation of the Method CaptHPV for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas"

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 19, 2016

Primary Completion Date

June 12, 2018

Study Completion Date

June 12, 2018

Conditions
Cervical CancerVulvar CancerAnal CancerOropharynx CancerOral Cavity CancerPenis Cancer
Interventions
OTHER

CaptHPV method

"20 ml of blood sample will be made before the beginning of all treatment. This blood sample will be sent to the CERBA Laboratory for analysis.~In parallel, a standard anatomopathological and virological analysis will be carried out from a biopsy or from a tumor sample by the Tumor Biology Unit at Lorraine Institute of Oncology~The results of both analyzes will be compared blindly."

Trial Locations (1)

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT02981862 - "CaptHPV : Validation of the Method CaptHPV for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas" | Biotech Hunter | Biotech Hunter